Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

22nd-Nov-2012 11:36Source: BSE

Aurobindo Pharm - Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated November 22, 2012, titled "Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)."

More Announcements on:

22nd-Nov-2017 14:01Source: NSE

Aurobindo Pharma Limited

22nd-Nov-2017 13:43Source: BSE

Aurobindo Pharma - Earnings Call Transcript

18th-Nov-2017 12:30Source: BSE

Aurobindo Pharma - Updates

16th-Nov-2017 10:08Source: BSE

Aurobindo Pharma - Investor Presentation

9th-Nov-2017 19:50Source: BSE

Aurobindo Pharma - Investor Presentation

9th-Nov-2017 19:47Source: BSE

Aurobindo Pharma - Meeting Updates

9th-Nov-2017 19:40Source: BSE

Aurobindo Pharma - Press Release / Media Release

1 2 3 4 5 Next >>
Sections
Follow us on
Available On